Insider sales are routine and non-informative at this scale, no bearish read-through.
CORT drugs
CORT drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 13 $110.51entry
- T+1 · 3mo ago +3.58%α +3.78% · $114.47
- T+5 · 3mo ago +9.54%α +11.50% · $121.05
- T+20 · 2mo ago +2.06%α +3.81% · $112.79
- T+60 · 11d ago −34.15%α −28.68% · $72.77
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite insiders at Corcept Therapeutics sold shares on August 10, 2026, totaling $662K in open-market sales. The sales follow derivative exercises and coincide with a period of strong stock performance (market cap $12.4B), but the dollar amount is trivial relative to company size (~0.005% of market cap), making this a routine liquidity event rather than a bearish signal.
Key Financial Metrics
Key Facts
- Chief Development Officer Guyer sold 16,300 shares total ($1.85M gross), with 4,770 shares at $114.04 and 11,530 shares at $113.18, all following derivative exercises
- See Remarks officer Maduck sold 1,031 shares at $114.52 ($118K) after exercising derivatives at $8.27
- Total open-market sales: $662K, representing ~0.005% of Corcept's $12.4B market cap
- Both sales occurred on the same day (Aug 10) after derivative exercises, consistent with tax-covering or routine diversification
- No insider purchases in the cluster; all cash transactions are sales
Financial Impact
Total open-market sales of $662K, immaterial relative to $12.4B market cap
Risk Factors
- Insider sales could accelerate if the stock continues to rally, but current volume is trivial
- No insider buying to signal confidence; all cash transactions are sells
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1786774478904 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers